Quick Takeaways: Why It Matters? By unifying Saladpet and Dogibogi under Kinfora, LIMPID should improve user retention, cross-sell higher-margin nutrition products, and gather denser longitudinal data that can support its “digital twin” ambition and future AI biomarker work in chronic dise...
Quick Takeaways: Why It Matters? LIMPID’s acquisition of PetPeotalk turns Kinfora into a richer, behaviour‑driven pet health platform, because it brings in a mature vision‑AI stack (Dogibogi) with real‑world scale, hundreds of millions of labelled behaviour ...
Quick Takeaways Why It Matters? A new proprietary CNS asset from Orion, exclusively commercialized by Zoetis in the US, that taps into fast‑growing demand for medical management of canine anxiety and should expand the addressable market beyond situational noise phobia toward mo...
